Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Heron Therapeutics (HRTX) Amortizatization of Intangibles (2016 - 2026)

Heron Therapeutics filings provide 14 years of Amortizatization of Intangibles readings, the most recent being $144000.0 for Q1 2026.

  • On a quarterly basis, Amortizatization of Intangibles fell 31.75% to $144000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $783000.0, a 3.3% increase, with the full-year FY2025 number at $744000.0, down 0.93% from a year prior.
  • Amortizatization of Intangibles hit $144000.0 in Q1 2026 for Heron Therapeutics, down from $239000.0 in the prior quarter.
  • In the past five years, Amortizatization of Intangibles ranged from a high of $1.7 million in Q4 2023 to a low of -$371000.0 in Q2 2023.
  • Median Amortizatization of Intangibles over the past 5 years was $200000.0 (2024), compared with a mean of $280705.9.
  • Biggest five-year swings in Amortizatization of Intangibles: skyrocketed 666.67% in 2022 and later tumbled 3472.73% in 2023.
  • Heron Therapeutics' Amortizatization of Intangibles stood at $574000.0 in 2022, then skyrocketed by 199.3% to $1.7 million in 2023, then crashed by 85.62% to $247000.0 in 2024, then decreased by 3.24% to $239000.0 in 2025, then crashed by 39.75% to $144000.0 in 2026.
  • The last three reported values for Amortizatization of Intangibles were $144000.0 (Q1 2026), $239000.0 (Q4 2025), and $200000.0 (Q3 2025) per Business Quant data.